|
Please use this identifier to cite or link to this item:
http://hdl.handle.net/10174/31656
|
Title: | Epidemiology and surveillance of human (neuro)cysticercosis in Europe: is enhanced surveillance required? |
Authors: | Abraham, Annette Vilhena, Maria Manuela Garcia, Hugo Winkler, Andrea Sylvia |
Editors: | John Wiley & Sons Ltd |
Keywords: | neurocysticercosis epidemiology Europe |
Issue Date: | May-2020 |
Publisher: | Tropical Medicine and International Health |
Citation: | Abraham A, Schmidt V, Kaminski M, Stelzle D, De Meijere R, Bustos J, Sahu PS, Garcia HH, Bobić B, Cretu C, Chiodini P, Deksne G, Dermauw V, Devleesschauwer B, Dorny P, Fonseca A, Gabriël S, Gómez-Morales MA, Kucsera I, Laranjo-González M, Trevisan C, Vilhena M, Walker NF, Zammarchi L, Winkler AS. Epidemiology and surveillance of human (neuro)cysticercosis in Europe: is enhanced surveillance required? Trop Med Int Health. 2020 May;25(5):566-578. doi: 10.1111/tmi.13384. Epub 2020 Mar 20. PMID: 32083787. |
Abstract: | objectives To report on relevant national surveillance systems of (N)CC and taeniasis (the infection
with the adult tapeworm) in the European Union/European Economic Area and to assess the
magnitude of (N)CC occurrence by retrieving information on cases for the period 2000–2016.
methods (N)CC cases were retrieved via national reporting systems, a systematic literature search,
contact with clinicians and a search for relevant ‘International Statistical Classification of Diseases
and Related Health Problems’ (ICD)-based data.
results Mandatory notification systems for (N)CC were found in Hungary, Iceland and Poland.
Ten cases were reported in Poland and none in Hungary and Iceland. Through the systematic
literature review and information given by clinicians, 263 individual and 721 aggregated (N)CC cases
from 19 European countries were identified. ICD-based data were obtained from five countries. From
2000 to 2016, a total of 3489 cases (N)CC cases were coded: 832 in Italy, eight in Latvia, 357 in
Portugal, 2116 in Spain and 176 in Sweden.
conclusion Despite being classified as a possible eradicable disease, (N)CC is still diagnosed across
Europe, yet its true extent and impact remain unclear. |
URI: | https://onlinelibrary.wiley.com/doi/full/10.1111/tmi.13384 http://hdl.handle.net/10174/31656 |
Type: | article |
Appears in Collections: | MED - Publicações - Artigos em Revistas Internacionais Com Arbitragem Científica
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|